Literature DB >> 12939222

Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.

Ralf Köhler1, Heike Wulff, Ines Eichler, Marlene Kneifel, Daniel Neumann, Andrea Knorr, Ivica Grgic, Doris Kämpfe, Han Si, Judith Wibawa, Robert Real, Klaus Borner, Susanne Brakemeier, Hans-Dieter Orzechowski, Hans-Peter Reusch, Martin Paul, K George Chandy, Joachim Hoyer.   

Abstract

BACKGROUND: Angioplasty stimulates proliferation and migration of vascular smooth muscle cells (VSMC), leading to neointimal thickening and vascular restenosis. In a rat model of balloon catheter injury (BCI), we investigated whether alterations in expression of Ca2+-activated K+ channels (KCa) contribute to intimal hyperplasia and vascular restenosis. METHODS AND
RESULTS: Function and expression of KCa in mature medial and neointimal VSMC were characterized in situ by combined single-cell RT-PCR and patch-clamp analysis. Mature medial VSMC exclusively expressed large-conductance KCa (BKCa) channels. Two weeks after BCI, expression of BKCa was significantly reduced in neointimal VSMC, whereas expression of intermediate-conductance KCa (IKCa1) channels was upregulated. In the aortic VSMC cell line, A7r5 epidermal growth factor (EGF) induced IKCa1 upregulation and EGF-stimulated proliferation was suppressed by the selective IKCa1 blocker TRAM-34. Daily in vivo administration of TRAM-34 to rats significantly reduced intimal hyperplasia by approximately 40% at 1, 2, and 6 weeks after BCI. Two weeks of treatment with the related compound clotrimazole was equally effective. Reduction of intimal hyperplasia was accompanied by decreased neointimal cell content, with no change in the rate of apoptosis or collagen content.
CONCLUSIONS: The switch toward IKCa1 expression may promote excessive neointimal VSMC proliferation. Blockade of IKCa1 could therefore represent a new therapeutic strategy to prevent restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939222     DOI: 10.1161/01.CIR.0000086464.04719.DD

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  91 in total

Review 1.  K+ channels as targets for specific immunomodulation.

Authors:  K George Chandy; Heike Wulff; Christine Beeton; Michael Pennington; George A Gutman; Michael D Cahalan
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

2.  Cell membrane stretch activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells.

Authors:  Yasunobu Hayabuchi; Yutaka Nakaya; Kazuaki Mawatari; Miki Inoue; Miho Sakata; Shoji Kagami
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

3.  Store-operated Ca(2+) entry is not essential for PDGF-BB induced phenotype modulation in rat aortic smooth muscle.

Authors:  Craig A Emter; Douglas K Bowles
Journal:  Cell Calcium       Date:  2010-07       Impact factor: 6.817

4.  KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Authors:  Serge Simonet; Marc Isabelle; Mélanie Bousquenaud; Nicolas Clavreul; Michel Félétou; Christine Vayssettes-Courchay; Tony J Verbeuren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 5.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

6.  Potassium channels and proliferation of vascular smooth muscle cells.

Authors:  William F Jackson
Journal:  Circ Res       Date:  2005-12-09       Impact factor: 17.367

7.  Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells.

Authors:  Han Si; Ivica Grgic; Willm-Thomas Heyken; Tanja Maier; Joachim Hoyer; Hans-Peter Reusch; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

8.  The role of cell cholesterol and the cytoskeleton in the interaction between IK1 and maxi-K channels.

Authors:  Victor G Romanenko; Kurt S Roser; James E Melvin; Ted Begenisich
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

9.  De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain.

Authors:  Alejandro Moreno-Domínguez; Pilar Cidad; Eduardo Miguel-Velado; José R López-López; M Teresa Pérez-García
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

10.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.